Evidence map›Paper›PMID 27295190›Full record

ArticleRheumatology international2016

Fifteen-year trend in information on the World Wide Web for patients with rheumatoid arthritis: evolving, but opportunities for improvement remain.

Jose Dionisio Castillo-Ortiz, Jose de Jesus Valdivia-Nuno, Andrea Ramirez-Gomez, Heber Garagarza-Mariscal, Carlos Gallegos-Rios, Gabriel Flores-Hernandez, Luis Hernandez-Sanchez, Victor Brambila-Barba, Jose Juan Castaneda-Sanchez, Zalathiel Barajas-Ochoa and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jose Dionisio Castillo-OrtizUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Jose de Jesus Valdivia-NunoUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Andrea Ramirez-GomezUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Heber Garagarza-MariscalUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Carlos Gallegos-RiosUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Gabriel Flores-HernandezUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Luis Hernandez-SanchezUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Victor Brambila-BarbaUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Jose Juan Castaneda-SanchezUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Zalathiel Barajas-OchoaUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Angel Suarez-RicoUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico.
Jorge Manuel Sanchez-GonzalezVicerrectoría Académica, Universidad Autónoma de Guadalajara, Avenida Patria 1201, Col. Lomas del Valle, 45129, Zapopan, Jalisco, Mexico.
Cesar Ramos-RemusUnidad de Investigacion en Enfermedades Cronico-Degenerativas, Colomos 2292, Providencia, 44620, Guadalajara, Jalisco, Mexico. r_ramos@prodigy.net.mx.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to assess the changes in the characteristics of rheumatoid arthritis information on the Internet over a 15-year period and the positioning of Web sites posted by universities, hospitals, and medical associations. We replicated the methods of a 2001 study assessing rheumatoid arthritis information on the Internet using WebCrawler. All Web sites and pages were critically assessed for relevance, scope, authorship, type of publication, and financial objectives. Differences between studies were considered significant if 95 % confidence intervals did not overlap. Additionally, we added a Google search with assessments of the quality of content of web pages and of the Web sites posted by medical institutions. There were significant differences between the present study's WebCrawler search and the 2001-referent study. There were increases in information sites (82 vs 36 %) and rheumatoid arthritis-specific discussion pages (59 vs 8 %), and decreases in advertisements (2 vs 48 %) and alternative therapies (27 vs 45 %). The quality of content of web pages is still dispersed; just 37 % were rated as good. Among the first 300 hits, 30 (10 %) were posted by medical institutions, 17 of them in the USA. Regarding readability, 7 % of these 30 web pages required 6 years, 27 % required 7-9 years, 27 % required 10-12 years, and 40 % required 12 or more years of schooling. The Internet has evolved in the last 15 years. Medical institutions are also better positioned. However, there are still areas for improvement, such as the quality of the content, leadership of medical institutions, and readability of information.

Indexed as

Arthritis, RheumatoidInformation DisseminationInternetComprehensionHumansHealth literacyInternetPatient educationReadabilityRheumatoid arthritisWorld Wide Web

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.